HLA-Class II alleles represent the more significant genetic contribution to MS risk, specifically within the DR15 haplotype: HLA-DRB1*15:01, is a common finding in MS populations, primarily those of Northern European descent [5]. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.